Home » Reports » Broker Ratings » Oxford BioMedica plc 25% Potential Upside Indicated by Jefferies International

Oxford BioMedica plc 25% Potential Upside Indicated by Jefferies International

Oxford BioMedica plc with EPIC/TICKER (LON:OXB) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘HOLD’ today by analysts at Jefferies International. Oxford BioMedica plc are listed in the Health Care sector within UK Main Market. Jefferies International have set a target price of 800 GBX on its stock. This indicates the analyst now believes there is a potential upside of 25.0% from the opening price of 640 GBX. Over the last 30 and 90 trading days the company share price has decreased 80.1 points and decreased 235.1 points respectively. The 1 year high share price is 1064.38 GBX while the 52 week low is 460 GBX.

Oxford BioMedica plc has a 50 day moving average of 702.22 GBX and the 200 Day Moving Average price is recorded at 797.41. There are currently 66,103,528 shares in issue with the average daily volume traded being 78,894. Market capitalisation for LON:OXB is £424,186,347 GBP.